FDA
-
-
-
-
-
-
-
Creative Medical Technology (CELZ) Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201
-
-
-
-
-
-
-
Novan (NOVN) Issues Corporate Update; Reports Q3 Results
-
-
-
-
-
-
-
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
-
-
-
-
-
-
-
Relief Selects CRO and CDMO for RLF-100TM in Europe
-
-
-
-
-
-
-
Syneos Health Appoints Patrick Nealon, Head of Oncology
-
-
-
-
-
-
-
LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider
-
-
251,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All